FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q89955342> ?p ?o ?g. }

• Q89955342 description "2020 nî lūn-bûn" @default.
• Q89955342 description "2020年の論文" @default.
• Q89955342 description "2020年学术文章" @default.
• Q89955342 description "2020年学术文章" @default.
• Q89955342 description "2020年学术文章" @default.
• Q89955342 description "2020年学术文章" @default.
• Q89955342 description "2020年学术文章" @default.
• Q89955342 description "2020年学术文章" @default.
• Q89955342 description "2020年學術文章" @default.
• Q89955342 description "2020年學術文章" @default.
• Q89955342 description "2020年學術文章" @default.
• Q89955342 description "2020年學術文章" @default.
• Q89955342 description "2020年學術文章" @default.
• Q89955342 description "2020년 논문" @default.
• Q89955342 description "article científic" @default.
• Q89955342 description "article scientific" @default.
• Q89955342 description "article scientifique" @default.
• Q89955342 description "articol științific" @default.
• Q89955342 description "articolo scientifico" @default.
• Q89955342 description "artigo científico" @default.
• Q89955342 description "artigo científico" @default.
• Q89955342 description "artigo científico" @default.
• Q89955342 description "artikel ilmiah" @default.
• Q89955342 description "artikull shkencor" @default.
• Q89955342 description "artikulong pang-agham" @default.
• Q89955342 description "artykuł naukowy" @default.
• Q89955342 description "artículo científico publicado en 2020" @default.
• Q89955342 description "artículu científicu" @default.
• Q89955342 description "bilimsel makale" @default.
• Q89955342 description "bài báo khoa học" @default.
• Q89955342 description "naučni članak" @default.
• Q89955342 description "scienca artikolo" @default.
• Q89955342 description "scientific article published on 30 January 2020" @default.
• Q89955342 description "scientific article published on 30 January 2020" @default.
• Q89955342 description "scientific article published on 30 January 2020" @default.
• Q89955342 description "teaduslik artikkel" @default.
• Q89955342 description "tieteellinen artikkeli" @default.
• Q89955342 description "tudományos cikk" @default.
• Q89955342 description "vedecký článok" @default.
• Q89955342 description "vetenskaplig artikel" @default.
• Q89955342 description "videnskabelig artikel udgivet 30. januar 2020" @default.
• Q89955342 description "vitenskapelig artikkel" @default.
• Q89955342 description "vitskapeleg artikkel" @default.
• Q89955342 description "vědecký článek" @default.
• Q89955342 description "wetenschappelijk artikel" @default.
• Q89955342 description "wissenschaftlicher Artikel" @default.
• Q89955342 description "επιστημονικό άρθρο" @default.
• Q89955342 description "мақолаи илмӣ" @default.
• Q89955342 description "наукова стаття, опублікована в січні 2020" @default.
• Q89955342 description "научна статия" @default.
• Q89955342 description "научная статья" @default.
• Q89955342 description "научни чланак" @default.
• Q89955342 description "научни чланак" @default.
• Q89955342 description "գիտական հոդված հրատարակված 2020 թվականի հունվարի 30-ին" @default.
• Q89955342 description "מאמר מדעי" @default.
• Q89955342 description "مقالة علمية نشرت في 30 يناير 2020" @default.
• Q89955342 description "৩০ জানুয়ারি ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q89955342 description "บทความทางวิทยาศาสตร์" @default.
• Q89955342 description "სამეცნიერო სტატია" @default.
• Q89955342 name "A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer" @default.
• Q89955342 name "A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer" @default.
• Q89955342 type Item @default.
• Q89955342 label "A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer" @default.
• Q89955342 label "A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer" @default.
• Q89955342 prefLabel "A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer" @default.
• Q89955342 prefLabel "A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer" @default.
• Q89955342 P1433 Q89955342-9E864F4B-22A6-4C04-A211-71787D9C2409 @default.
• Q89955342 P1476 Q89955342-B95ED8A3-4C28-4BDE-A2A7-AFE9E8E516AB @default.
• Q89955342 P2093 Q89955342-13F8FA4D-0A4D-492C-85CF-00CF966DA425 @default.
• Q89955342 P2093 Q89955342-2C16EC13-12F5-4185-B18C-A7849D50C34D @default.
• Q89955342 P2093 Q89955342-381C2EE4-4AB9-4654-8B41-8759A08A80B5 @default.
• Q89955342 P2093 Q89955342-44C25492-4A3F-4475-895E-5403D21229EF @default.
• Q89955342 P2093 Q89955342-526A6A34-C91B-4F8C-975B-AE0FDEB762CD @default.
• Q89955342 P2093 Q89955342-6F313627-0A38-4987-95DA-F57613A70D32 @default.
• Q89955342 P2093 Q89955342-6F4B22BD-2CC9-4D1C-A26A-7D12BD236235 @default.
• Q89955342 P31 Q89955342-9F6C729B-64EA-4B34-9626-6A75D38FF739 @default.
• Q89955342 P356 Q89955342-633473F0-3FF0-4FB5-90D3-EF92ECB3E6CC @default.
• Q89955342 P50 Q89955342-4A15760B-9CF2-4A46-90DB-7EEC0683F393 @default.
• Q89955342 P50 Q89955342-5655FD57-CED8-4ADE-B231-6909C368EA95 @default.
• Q89955342 P50 Q89955342-B1ACC014-E48A-4FE3-B17E-9D55313B37D6 @default.
• Q89955342 P50 Q89955342-E1B452A1-06BB-40F8-813B-6B8D063C7EB5 @default.
• Q89955342 P50 Q89955342-F78A7FD4-B364-4706-86BE-461AB50E0901 @default.
• Q89955342 P50 Q89955342-F8CADD58-12CC-4E3F-9337-5D94130CE249 @default.
• Q89955342 P50 Q89955342-FEA5DD2B-678F-4B7F-B0F6-3D6E362EA777 @default.
• Q89955342 P50 Q89955342-FF53E7FC-D193-4349-8E63-B5218AA35FEF @default.
• Q89955342 P577 Q89955342-28F1BEF0-35E9-423D-9464-7B0047EA5801 @default.
• Q89955342 P698 Q89955342-C2A1186E-ED6F-461F-8D81-BD238A5B09F0 @default.
• Q89955342 P921 Q89955342-0752ED2C-0801-41F7-A024-BEFED69CDD6D @default.
• Q89955342 P921 Q89955342-7D5E66CF-A2F0-4C48-B425-225D8549510F @default.
• Q89955342 P356 J.CLBC.2020.01.012 @default.
• Q89955342 P698 32113750 @default.
• Q89955342 P1433 Q332245 @default.
• Q89955342 P1476 "A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer" @default.
• Q89955342 P2093 "Chelsea Andrews" @default.
• Q89955342 P2093 "Deborah Dillon" @default.
• Q89955342 P2093 "Edward T Richardson" @default.
• Q89955342 P2093 "Elizabeth A Mittendorf" @default.
• Q89955342 P2093 "Jonathan D Schoenfeld" @default.
• Q89955342 P2093 "Ricardo G Pastorello" @default.
• Q89955342 P2093 "Tianyu Li" @default.

• next